4-85994814-T-C
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001025616.3(ARHGAP24):c.1160T>C(p.Met387Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,613,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M387I) has been classified as Likely benign.
Frequency
Consequence
NM_001025616.3 missense
Scores
Clinical Significance
Conservation
Publications
- Lennox-Gastaut syndromeInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152060Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000478 AC: 12AN: 251196 AF XY: 0.0000810 show subpopulations
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1461886Hom.: 0 Cov.: 33 AF XY: 0.0000495 AC XY: 36AN XY: 727246 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152060Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74282 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1160T>C (p.M387T) alteration is located in exon 9 (coding exon 8) of the ARHGAP24 gene. This alteration results from a T to C substitution at nucleotide position 1160, causing the methionine (M) at amino acid position 387 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
ARHGAP24-related disorder Uncertain:1
The ARHGAP24 c.1160T>C variant is predicted to result in the amino acid substitution p.Met387Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at